Aspect Biosystems is a Canadian biotechnology company combining the power of microfluidics and 3D bioprinting to develop bioprinted therapeutics as medicines of the future. By adopting Aspect’s microfluidic 3D bioprinting platform and collaborating within Aspect’s network, our academic collaborators are accelerating the development and commercialization of 3D bioprinted tissues. In addition, Aspect is advancing its internal regenerative medicine programs focused on bioprinted therapeutics to treat type 1 diabetes and liver disorders.

AXT is a leading supplier of cutting-edge scientific solutions. We have a dedicated and extensive bioprinting portfolio sourced from leading international suppliers:

* Regenhu – Highly configurable bioprinting platforms for research and industrial-scale applications
* Poeitis – Next Generation lazer assisted bioprinters to create real human tissue
* Fluicell – Pioneers in single cell technology and single cell bioprinting
* UpNano – Biofabrication with unprecedented speed and accuracy

For more information, please visit

CELLINK is the leading bioconvergence company in the world that provides technologies to create, understand and master biology. With a focus on the application areas of bioprinting, multiomics, cell line development and diagnostics, the company develops and markets innovative technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissue and organs for the medical, pharmaceutical and cosmetic industries. CELLINK’s products are trusted by 2,000+ laboratories, including ones at all the top 20 pharmaceutical companies, are being used in 65+ countries, and have been cited in 1,700+ publications.

CollPlant is a regenerative medicine company developing technologies and products for tissue regeneration and organ manufacturing.

CollPlant developed a technology for mass production of rhCollagen in genetically-engineered tobacco plants, which is identical to the collagen produced by the human body.

CollPlant’s product pipeline includes 3D bioprinted implants for breast reconstruction and augmentation, 3D bioprinted surgical mesh for use in breast reconstruction procedures (in collaboration with 3D Systems), and a portfolio of bioinks for various indications.

Inventia Life Science is a fast-growing biotechnology startup based in Sydney, Australia, that is revolutionising cancer research, drug discovery and regenerative medicine. Inventia’s digital drop-on-demand 3D bioprinting technology is a game changer for the rapid fabrication of living biological structures. The company’s RASTRUM 3D cell culture platform, winner of the 2019 Good Design Award of the Year and 2020 Fast Company World Changing Ideas Award, has already been adopted in leading medical research institutes creating printed 3D tissues that model real biology. Inventia Life Science is also working with its customers and collaborators on new high-throughput personalised screening approaches as well as with clinical partners to advance regenerative medicine in areas such as bioprinted skin for the repair of burns and wounds.

Objective3D is Australia and New Zealand’s leading provider of best-in-class Additive Manufacturing (AM) solutions from Stratasys, Lithoz, Desktop Metal, GE Additive as well as a supplier of professional Artec3D Scanners and Materialise AM Software. Objective3D also provides manufacturing on-demand services with an extensive range of FDM, PolyJet, SLS, and Metal technologies and is supported by the Stratasys Direct Manufacturing Global Network. Objective3D is ISO 9001 certified and a multi-year winner of customer satisfaction awards.

READILY3D helps biologists push the frontiers of biofabrication by providing rapid easy-to-use volumetric 3D printers.

As the most recent strategic segment within Rousselot, we have drawn upon Rousselot’s 125+ years of worldwide expertise and proven track record of pharmaceutical gelatins and collagens to develop X-Pure®, an innovative range of purified gelatins and collagens specifically designed for (bio)medical applications. Offering unique advantages to assure performance, quality and safety, X-Pure is backed by strong scientific data and on-going research. Rousselot Biomedical is committed to facilitating the use of X-Pure in your applications and to help “Advancing medical science”.

TRUMPF was founded in 1923 as a series of mechanical workshops and has since developed into one of the world’s leading companies for machine tools, laser technology, and electronics for industrial applications. Our mission is to further develop and digitally connect production technology, to make it even more efficient, precise, and future-proof.

We offer laser sources and flexible laser systems and technology support for micro processing, laser marking, laser cutting and welding, as well as additive manufacturing.

Wiley, a global company, helps people and organizations develop the skills and knowledge they need to succeed. Our online scientific, technical, medical, and scholarly journals, combined with our digital learning, assessment and certification solutions help universities, societies, businesses, governments, and individuals increase the academic and professional impact of their work.